
R&D and Innovation
R&D and Innovation
Product Pipeline
FDF:
Product Name | Main Indication |
Clindamycin Phosphate Injection 4ml:0.6g, 2ml:0.3g | Antibacterials |
Levofloxacin Hydrochloride Injection 5ml:0.5g, 5ml:0.3g | Antibacterials |
Fleroxacin Injection 10ml:0.4g, 10ml:0.2g, 10ml:0.1g | Antibacterials |
Azithromycin Lactobionate Injection 5ml:0.5g, 2.5ml:0.25g | Antibacterials |
Cefoperazone Sodium and Sulbactam Sodium for Injection 1.0g | Beta-Lactam Antibacterials |
Ganciclovir Injection 20ml:0.25g |
1. Cytomegalovirus retinitis in immunodeficiency patients (including AIDS patients) 2. Prevent cytomegalovirus infection that may occur in recipients of organ transplants |
Pefloxacin Mesylate Injection 5ml:0.4g, 2ml:0.2g | Antiinfectives |
Lidocaine Hydrochloride Injection 5ml:0.1g, 20ml:0.4g | Local anesthetics |
Lidocaine hydrochloride injection(for solvent) 5ml:10mg, 2ml:4mg | Local anesthetics |
Propyl Gallate Injection 5ml:60mg, 10ml:120mg | Anti-thrombotic drugs |
Puerarin Injection 8ml:0.4g, 5ml:0.25g | Cerebrovascular and peripheral vasodilators |
Marine Injection 5ml:0.6g | Hepatobiliary medication |
Vitamin C Injection 5ml:0.5g, 2ml:0.25g, 2ml:0.1g | Scurrvy,various acute and chronic infectious diseases and purpura,chronic iron poisoning,idiopathic methemoglobinemia |
Vitamin B12 Injection 1ml:1mg, 1ml:0.5mg, 1ml:0.25mg, 1ml:0.1mg, 1ml:0.05mg | Megaloblastic anemia,and also used for adjuvant treatment of neuritis |
Lappaconitine Hydrobromide Injection 2ml:4mg | Moderate or higher pain |
Piroxicam Injection 2ml:20mg | Symptomatic treatment for pain and swelling of various arthritis and soft tissue lesions |
Aceglutamide Injection 2ml:100mg | Traumatic brain coma, coma caused by neurosurgery, liver coma and hemiplegia, high paraplegia, sequelae of polio, neurological headache and low back pain |
Diazepam Injection 2ml:10mg | Hypnotics and Sedatives |
API:
Product Name | Main Indication |
Varenicline Tartrate | Smoking cessation drugs for adults |
Aprepitant | Prevent acute and delayed nausea and vomiting caused by chemotherapy |
Fosaprepitant Dimeglumine | Chemotherapy antiemetics |
Vildagliptin | Type 2 diabetes |
Efinaconazole | Topical triazole antifungal |
Gadoterate Meglumine | MRI contrast agent |
Gadobutrol | MRI contrast agent |
Mirabegron | Symptomatic treatment of urgency, frequency and/or urge incontinence in adults with overactive bladder (OAB) |
Luliconazole | Fungal Infections |
Atazanavir sulfate | Combination for HIV-1 infection |